Transplantation of Unmanipulated Allogeneic PBSC: Preliminary Report on 24 Patients

References

• To L. B., Roberts M. M., Haylock D. N., et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic transplants. Bone Marrow Transplant 1992; 9: 277–284
   PubMed Web of Science ®Google Scholar
• Majolino I., Pearce R., Taghipour G., Goldstone A. H. PBSCT vs ABMT in Hodgkin's and non-Hodgkin's lymphomas. A new matched-pair analysib of the EBMT Registry data. Bone Marrow Transplant 1995; 15: 162, (abstract)
   Google Scholar
• Bacigalupo A., Piaggio G., Podesta M., et al. Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15: 221–226
   PubMed Web of Science ®Google Scholar
• Weaver C. H., Buckner C. D., Longin K., et al. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993; 82: 1981–1984
   PubMed Web of Science ®Google Scholar
• Bensinger W. I., Price T. H., Dale D. C., et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883–1888
   PubMed Web of Science ®Google Scholar
• Dreger P., Suttorp M., Haferlach T., Loftler M., Schmitz N., Schroyens W. Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993; 81: 1404–1407, (letter)
   PubMed Web of Science ®Google Scholar
• Russell N. H., Hunter A., Rogers S., Hanley J., Andersnn D. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancer 1993; 341: 1482, (letter)
   PubMed Web of Science ®Google Scholar
• Bacigalupo A., Majolino I., Van Lint M. T., et al. Transplantation of rhG-CSF mobilized allogeneic peripheral blood cells from HLA identical sibling donors. Bone Marrow Transplant 1995; 15(suppl 2)5, (abstract)
   Google Scholar
• Bensinger W. I., Weaver C. H., Appelbaum F. R., et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Blood 1995; 85: 1659–1665
   PubMed Web of Science ®Google Scholar
• Körbling M., Przepiorka D., Huh Y. O., et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1655–1658
   PubMed Web of Science ®Google Scholar
• Schmitz N., Dreger P., Suttorp M., et al. Primary transplantation of allogeneic peripheral blood cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666–1672
   PubMed Web of Science ®Google Scholar
• Buscemi F., Fabbiano F., Felice R., et al. Use of large polygonal gates for flow cytometry analysis of circulating progenitor cells. Bone Marrow Transplant 1993; 12: 305–306, (letter)
   PubMed Web of Science ®Google Scholar
• Majolino I., Saglio G., Scimè R., et al. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplant 1996; 17: 555–560
   PubMed Web of Science ®Google Scholar
• Griffiths P. D., Panjwani D. D., Stirk P. R., et al. Rapid diagnosis of cytomegalovirus infection in immunocom-promised patients by detection of early antigen fluorescent foci. Lancet 1984; ii: 1242–1244
   Google Scholar
• van der Bij W., Torensma R., van Son W. J., et al. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol 1988; 25: 179–188
   PubMed Web of Science ®Google Scholar
• Urban-Ispizua A., Solano C., Brunet S., et al. Allogeneic peripheral blood progenitor cell transplantation: analysis of shon-term engraftment and acute GVHD incidence in 33 cases. Bone Marrow Transplant 1996; 18: 3540
   Google Scholar
• Carbonel F., Calvo W., Fliedner T. M., et al. Cytogenetic studies in dogs after total body irradiation and allogeneic transfusion with cryopreserved blood mononuclear cells: observations in long-term chimeras. Int J Cell Clon 1984; 2: 81–88
   PubMedGoogle Scholar
• Molineux G., Pojda Z., Hampson I. N., Lord B. I., Dexter T. M. Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 1990; 76: 2153–2158
   PubMed Web of Science ®Google Scholar
• Atkinson K., Farrell C., Chapman G., Downs K., Penny R., Biggs J. Female marrow donors increase the risk of acute graft-versus-host-disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum. Br J Haematol 1986; 63: 231–239
   PubMed Web of Science ®Google Scholar
• Storb R., Deeg H. J., Whitehead J., et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after bone marrow transplantation for leukemia. New Eng J Med 1986; 314: 729–735
   PubMed Web of Science ®Google Scholar
• Kolb H. J., Mittermüller J., Clemm C. H., et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462–2465
   PubMed Web of Science ®Google Scholar
• Bernasconi P., Alessandrino E. P., Caldera D., et al. Intensive chemotherapy followed by donor PBSC in ANLL relapsed after allogeneic BMT. Bone Marrow Transplant 1995; 15: 643–645
   PubMed Web of Science ®Google Scholar